EMP3 expression was found to be correlated with the activation of TGF-β/Smad2/3 signaling by interaction with TGFBR2, which resulted in TGF-β stimulated gene expression and tumor cell proliferation [27]. The gene discussed is SMAD2; the disease is neoplasm.